Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents.
about
Anticancer mechanisms of cannabinoidsCannabinoids as therapeutic agents in cancer: current status and future implicationsColon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.Understanding the cellular function of TRPV2 channel through generation of specific monoclonal antibodies.Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β.Molecular Targets of Cannabidiol in Neurological DisordersGPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responsesCannabidiol changes P-gp and BCRP expression in trophoblast cell linesWhat do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel?Molecular Targets of the Phytocannabinoids: A Complex Picture.Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor ProgressionSystematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas.Involvement of tumor acidification in brain cancer pathophysiology.New insights into pharmacological tools to TR(i)P cancer up.Trafficking of ThermoTRP Channels.TRPC Channels: Prominent Candidates of Underlying Mechanism in Neuropsychiatric Diseases.Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer.The evolving role of the endocannabinoid system in gynaecological cancer.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive CannabinoidTRPing on the pore phenomenon: what do we know about transient receptor potential ion channel-related pore dilation up to now?Role of TRP ion channels in cancer and tumorigenesis.Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture.Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.Calcium Channels and Associated Receptors in Malignant Brain Tumor Therapy.Regulation of surface expression of TRPV2 channels in the retinal pigment epithelium.Role of methamphetamine on glioblastoma cytotoxicity induced by doxorubicin and methotrexate.Molecular Pharmacology of Phytocannabinoids.Neurodegeneration and the Brain Tumor Microenvironment. [corrected]Placing ion channels into a signaling network of T cells: from maturing thymocytes to healthy T lymphocytes or leukemic T lymphoblasts.Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration.Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.Gene expressions of TRP channels in glioblastoma multiforme and relation with survival.The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.A TRPV2 interactome-based signature for prognosis in glioblastoma patients.Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs.TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancerCa Signaling and IL-8 Secretion in Human Testicular Peritubular Cells Involve the Cation Channel TRPV2
P2860
Q26750399-252E42EC-5FD5-4278-AFAA-245851479394Q26866298-F8929BA8-398B-4EC1-9768-9389EEEA7C98Q34441093-755FAE50-7D2D-4734-93E4-82025998D957Q35083114-05EF873D-F16A-43DF-9630-BCA0BA18CA19Q35202838-C7C6DEE2-9F6C-4E03-84C2-7901AC4BE820Q36157649-C5F2B129-D07E-4296-B5AE-D541F0F2772BQ36398022-35FE778D-12EF-4FA3-922C-724ECDD0EBE0Q36610147-1F4134F1-9677-484D-A607-CC6559D7670FQ37178591-E70E5096-23CF-465F-A310-AB7A2CE29EBFQ37198480-F206E0B5-363E-4BF7-8F1D-A767D51FBB99Q37692746-04B919B2-B2EB-4B8D-B66E-E31FCA4693CAQ37693612-D6264602-7881-4E23-A08F-5FBE23981A32Q38154188-2DB72763-8D28-4BD4-94D5-A9BB3ECFDB05Q38160479-E152CE33-D6AA-4919-A475-3057AFCCCFD6Q38171864-96174B6D-8A4C-441B-AB8C-DAF8FEA5CB1BQ38254512-470A5677-D602-44CF-9CB7-7E4FB6BD8C62Q38287204-DDA5CD49-8F5A-4088-8442-CC4717A0F066Q38369000-562C7C06-F1EF-41A1-813C-0313831A6405Q38469671-28455D94-5A7E-4802-9A19-959E308FA995Q38503842-DA5C526D-AF06-4A9D-89FF-84CA6C772BD0Q38634379-E5CE9DE9-4E9F-478C-9629-AE209FB387F9Q38686108-7D8B49B9-E851-42FD-AEDA-6801562AAD6AQ38722167-4527FA6B-97CB-49B7-ABC9-C460C58ABF39Q38732473-B75CBBFE-1DB8-49F7-A302-B75271CF469EQ38883388-95631234-A20B-4B38-A8D2-626928FC712DQ38897530-B13BCC96-1BC8-4C1C-87BE-EF5B086ACAC3Q38917001-DA84963A-07E9-4BC0-815B-3415B2C97E6FQ39013381-7FD7D9F9-17A5-4C49-80BF-39D7A3132B37Q39102188-D4FAA289-CF07-42B5-B3CE-36EF5A28BC90Q40494622-DA776A77-74E4-44E1-A823-C953575FE90FQ42061814-5A8FC0DB-A041-44BF-9FC2-7FBD6D423767Q42314593-344D7CAC-D56B-4B7D-8C2F-D6FD7921194EQ42700473-8BA50A32-A4D3-46DB-9BDF-7CC2883E5470Q51489436-ABF93BC4-786E-4CDC-8E42-9957B114864BQ53080643-E52AF364-F53F-49FC-92E8-C39E5BD5A236Q53688949-2C7C784E-149B-40E6-99B7-F26044CFEF1FQ54943187-27C9C96B-61F9-4ADA-8EFE-2DF8340331E3Q57498794-D3A91B4B-58C8-4400-8DD9-53B87DCB2DC4Q58715931-64AA732F-52CF-43DE-9313-118E9DAE5A72
P2860
Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Triggering of the TRPV2 channe ...... toxic chemotherapeutic agents.
@en
Triggering of the TRPV2 channe ...... toxic chemotherapeutic agents.
@nl
type
label
Triggering of the TRPV2 channe ...... toxic chemotherapeutic agents.
@en
Triggering of the TRPV2 channe ...... toxic chemotherapeutic agents.
@nl
prefLabel
Triggering of the TRPV2 channe ...... toxic chemotherapeutic agents.
@en
Triggering of the TRPV2 channe ...... toxic chemotherapeutic agents.
@nl
P2860
P50
P921
P356
P1433
P1476
Triggering of the TRPV2 channe ...... toxic chemotherapeutic agents.
@en
P2860
P356
10.1093/CARCIN/BGS328
P407
P577
2012-10-18T00:00:00Z